Patents by Inventor Ingo Bernard

Ingo Bernard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy comprising diaryl ureas for treating diseases
    Publication number: 20090306020
    Abstract: The present invention relates to pharmaceutical compositions and combinations for treating cancer, comprising a diaryl urea compound and an PI3K/AKT signaling pathway inhibitor. Useful combinations include e.g. BAY-43-9006 as a diaryl urea compound.
    Type: Application
    Filed: May 13, 2006
    Publication date: December 10, 2009
    Applicant: Bayer Healthcare AG
    Inventors: Urban Scheuring, Ingo Bernard, Claus Garbe, Birgit Schittek, Friedegund Meier
  • Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
    Publication number: 20090192127
    Abstract: The present invention relates to pharmaceutical compositions and combinations for treating cancer, comprising a diaryl urea compound e.g. 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and an PI3K/AKT signaling pathway inhibitor The PI3K/AKI signaling pathway inhibitor comprises PI3 inhibitors {like celecoxilo, viridins, wortmannins}, AKT kinase inhibitors {like perifosine, triciribine} and mTOR inhibitors {like the rapamycins temsirolimus and evorolimus}.
    Type: Application
    Filed: May 13, 2006
    Publication date: July 30, 2009
    Applicant: Bayer Healthcare AG
    Inventors: Urban Scheuring, Ingo Bernard